Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen.
Pharmacogenomics and Personalized Medicine（2021）
Key words
UGT1A1*6/*28 polymorphism,irinotecan toxicity,pediatric,relapsed/refractory solid tumors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined